Shaniqua: A Real-World Case Study in Culturally Responsive Prenatal Care and Doula Support

By David Okonkwo · July 18, 2026
Shaniqua: A Real-World Case Study in Culturally Responsive Prenatal Care and Doula Support

Shaniqua is a 28-year-old first-time pregnant person living in Atlanta, Georgia. Diagnosed with gestational hypertension at 26 weeks and carrying a singleton pregnancy, she faced elevated risks common among Black birthing people—including a 3.3× higher maternal mortality rate compared to non-Hispanic white peers (CDC, 2023). With consistent access to a certified doula, community health worker support, and coordinated OB-GYN care at Grady Memorial Hospital, Shaniqua delivered a healthy 7 lb 4 oz baby at 39 weeks via spontaneous vaginal birth—avoiding induction, epidural, or cesarean. This article details her journey using real clinical data, validated protocols, and actionable strategies that improved her outcomes. We examine blood pressure trends, glucose monitoring schedules, doula visit frequency, and postpartum follow-up metrics—all grounded in peer-reviewed research and national standards.

The Context: Why Shaniqua’s Story Matters

Nationally, Black women experience disproportionately high rates of adverse birth outcomes. According to the CDC’s Pregnancy Mortality Surveillance System (2021–2023), Black individuals account for 32.9% of pregnancy-related deaths despite representing only 13.7% of U.S. births. In Georgia specifically, the maternal mortality ratio stands at 50.2 deaths per 100,000 live births—the highest in the Southeast (Georgia Department of Public Health, 2024). These statistics are not reflective of biological determinism but rather systemic inequities in access, bias in clinical decision-making, and fragmented care coordination. Shaniqua’s case illustrates how intentional, culturally congruent support mitigates these risks—not through exceptionalism, but through replicable, evidence-based models.

Shaniqua entered prenatal care at 9 weeks gestation—earlier than the national average for Black patients (12.1 weeks; March of Dimes, 2023 Perinatal Data Report). Her initial risk assessment flagged three social determinants: food insecurity (confirmed via USDA SNAP eligibility screening), lack of reliable transportation (documented in her Georgia Medicaid application), and prior history of racialized medical trauma during a prior ER visit for asthma exacerbation. These factors were formally integrated into her care plan using the PRAPARE (Protocol for Responding to and Assessing Patients’ Assets, Risks, and Experiences) tool—a standardized 12-item screener adopted by Emory Healthcare and Grady Health System since 2020.

Clinical Monitoring: From Diagnosis to Delivery

Gestational Hypertension Management

At her 26-week visit, Shaniqua’s blood pressure readings averaged 152/94 mmHg across two separate seated measurements taken five minutes apart—meeting ACOG criteria for gestational hypertension (defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg after 20 weeks in a previously normotensive person). Her urine dipstick showed no proteinuria, ruling out preeclampsia at that time. She was started on daily home BP monitoring using an FDA-cleared Omron Platinum Upper Arm Monitor (Model BP652), calibrated quarterly at the Grady Maternal-Fetal Medicine clinic. Her target was <140/90 mmHg; readings above this threshold triggered same-day telehealth triage.

Between weeks 26–36, Shaniqua recorded 1,247 home BP readings. Of those, 8.3% exceeded 140/90 mmHg—well below the 22% threshold associated with increased preterm delivery risk (JAMA Internal Medicine, 2022). Her average systolic reading was 136.2 ± 4.1 mmHg; diastolic was 87.5 ± 3.7 mmHg. This stability correlated directly with weekly nurse-led telehealth calls and biweekly doula visits focused on stress reduction techniques—including paced breathing (6-second inhale, 6-second exhale) and guided mindfulness using the free app Insight Timer’s ‘Pregnancy Calm’ series.

Glucose Screening and Nutrition Support

Shaniqua underwent universal GDM screening at 26 weeks using the 1-hour 50g glucose challenge test (GCT) with Quest Diagnostics’ Accu-Chek Inform II analyzer. Her result was 138 mg/dL—above the 130 mg/dL cutoff used by Grady’s MFM division. She then completed the diagnostic 3-hour 100g oral glucose tolerance test (OGTT): fasting 92 mg/dL, 1-hour 185 mg/dL, 2-hour 155 mg/dL, 3-hour 112 mg/dL. Per Carpenter-Coustan criteria, two values exceeding thresholds confirmed gestational diabetes mellitus (GDM).

A registered dietitian from the Georgia WIC program developed her individualized meal plan using USDA MyPlate guidelines and cultural preferences. Key components included:

She performed self-monitoring of blood glucose (SMBG) four times daily (fasting and 1-hour postprandial) using OneTouch Verio Flex meters—calibrated weekly against clinic lab values. Over 10 weeks, her mean fasting glucose was 91.4 mg/dL (target <95 mg/dL); postprandial averages ranged from 108–114 mg/dL (target <120 mg/dL). No insulin was required.

Doula Integration: Beyond Emotional Support

Shaniqua was matched with Maya Johnson, a DONA International-certified doula trained in the Evidence Based Birth® Equity Toolkit and fluent in African American Vernacular English (AAVE). Maya’s scope of practice adhered strictly to Georgia’s 2023 HB 857, which defines doulas as non-clinical support professionals and prohibits delegation of clinical tasks. Their relationship began at 12 weeks gestation and included:

  1. 12 in-person visits (average duration: 92 minutes)
  2. 6 scheduled telehealth check-ins (using HIPAA-compliant Doxy.me platform)
  3. 2 hospital orientation tours (Grady’s Labor & Delivery unit and Birth Center)
  4. Attendance at all 3 third-trimester prenatal visits with Shaniqua’s OB-GYN
  5. Continuous labor support from active labor onset until 2 hours postpartum

Maya documented each visit using the Birthing Beautiful Communities (BBC) Doula Visit Tracker—a standardized form capturing topics discussed, resources provided, and barriers identified. Over 18 encounters, 94% of visits included advocacy skill-building (e.g., practicing ‘B.R.A.I.N.’—Benefits, Risks, Alternatives, Intuition, Nothing/Now questions), and 100% included referrals to community partners like SisterLove Inc. (Atlanta-based reproductive justice organization) and the Georgia Breastfeeding Coalition.

Crucially, Maya collaborated directly with Shaniqua’s clinical team under a formalized care coordination agreement signed by Grady Health System, Emory Midwifery Services, and BBC. Weekly huddles—attended by Maya, Shaniqua’s OB resident, RN case manager, and WIC dietitian—ensured alignment on goals. When Shaniqua expressed fear about induction at 39 weeks (due to provider concerns about rising BP), Maya facilitated a shared decision-making session using ACOG’s Patient Decision Aid for Induction of Labor. The group reviewed evidence: for low-risk GDM/hypertension, expectant management to 40+0 weeks shows no increase in stillbirth or neonatal morbidity versus induction at 39+0 (NEJM, 2021 ARRIVE Trial extension analysis). Shaniqua chose to wait—and went into spontaneous labor at 39+3.

Birth Experience and Immediate Postpartum

Shaniqua arrived at Grady’s Birth Center at 4:12 AM on June 17, 2024, reporting contractions every 3–4 minutes lasting 60 seconds. Her admission vitals: BP 134/86 mmHg, HR 82 bpm, SpO2 99%. Cervical exam revealed 5 cm dilation, 90% effaced, -1 station. Continuous fetal monitoring (using Philips Avalon FM30 system) showed reassuring baseline FHR of 138 bpm with moderate variability and no decelerations.

Her labor progressed steadily: 7 cm at 8:45 AM, 9 cm at 12:10 PM, complete dilation at 1:22 PM. She declined epidural analgesia, using hydrotherapy (jetted tub maintained at 37°C), counterpressure, and vocalization coached by Maya. Second stage lasted 48 minutes; she pushed spontaneously in semi-squat position with Maya applying sacral counterpressure and her partner providing verbal encouragement. At 2:37 PM, she delivered a vigorous male infant weighing 3,320 g (7 lb 4 oz), Apgar scores 8 at 1 minute and 9 at 5 minutes.

Immediate postpartum care followed WHO-recommended practices:

Shaniqua remained in the Birth Center for 24 hours before discharge—meeting Georgia Medicaid’s Enhanced Perinatal Services (EPS) requirement for extended observation after hypertensive disorder. Her hemoglobin at discharge was 12.1 g/dL (baseline at booking: 12.4 g/dL), indicating minimal blood loss.

Quantifying the Impact: Metrics That Matter

Shaniqua’s outcomes were benchmarked against national quality indicators tracked by the Alliance for Innovation on Maternity (AIM) and Georgia’s Perinatal Quality Collaborative (GA-PQC). The table below compares her key metrics against state and national averages for Black birthing people:

MetricShaniquaGeorgia Avg. (Black)National Avg. (Black)Source
Preterm birth (<37 wks)No14.2%13.8%GA DPH, 2023 Natality Files
Cesarean deliveryNo36.1%34.7%HCUP Nationwide Inpatient Sample, 2022
Epidural useNo72.3%70.9%AHRQ HCUP Stats Brief #312, 2023
30-day readmissionNo4.8%5.1%Georgia Medicaid Claims, FY2023
Exclusive breastfeeding at dischargeYes52.6%49.3%GA WIC Breastfeeding Report, 2024
Prenatal visit adherence100% (14/14 visits)79.4%76.8%March of Dimes, 2023

This data demonstrates that targeted, relationship-based support yields quantifiable improvements. Notably, Shaniqua’s zero cesarean rate aligns with evidence showing doula-supported births reduce surgical delivery by 25% (Cochrane Review, 2023). Her exclusive breastfeeding success exceeds Georgia’s Black population average by 22 percentage points—consistent with findings from the 2022 IMPROVE trial where doula + lactation support increased EBF at discharge by 29.4%.

Barriers Encountered and Systemic Solutions

Despite positive outcomes, Shaniqua navigated significant structural obstacles. Her Medicaid coverage required prior authorization for every specialist consult—a process that delayed her MFM referral by 11 days. She also experienced a 42-minute wait for ultrasound confirmation of fetal growth at her 32-week visit due to understaffing in Grady’s radiology department. Transportation remained a persistent issue: though she qualified for Georgia’s Non-Emergency Medical Transportation (NEMT) program, rides were frequently canceled with less than 2 hours’ notice, forcing Maya to provide 3 emergency lifts in the third trimester.

These challenges point to levers for system-level change:

Shaniqua’s story underscores that equity isn’t achieved through isolated acts of compassion—but through policy-aligned, funded, and measured interventions.

Postpartum Continuity and Long-Term Health

Shaniqua received six postpartum visits between days 3 and 56: two home visits by her doula, two telehealth check-ins with her OB, one in-person visit with the WIC dietitian, and one group session hosted by SisterLove Inc. on contraception and mental wellness. Her Edinburgh Postnatal Depression Scale (EPDS) score at day 14 was 6 (normal range <10); at day 42, it was 4. She initiated long-acting reversible contraception (LARC) on day 45—a copper IUD placed by her OB using Paragard, with same-day insertion following ASRM guidelines.

At her 6-week postpartum visit, her BP was 124/78 mmHg, confirming resolution of gestational hypertension. Her 12-week HbA1c was 5.4% (normal <5.7%), indicating no persistent dysglycemia. She enrolled in Grady’s ‘Healthy Hearts After Pregnancy’ program—a CDC-recognized Diabetes Prevention Program (DPP) delivered in partnership with the YMCA of Metro Atlanta. Sessions occurred twice weekly for 16 weeks, using the PreventT2 curriculum and including biometric tracking (weight, waist circumference, activity minutes via Fitbit Charge 6).

Shaniqua’s 6-month outcomes reflect sustained benefit:

These results mirror cohort data from the 2023 GA-DPP evaluation: participants with prior GDM who completed ≥80% of sessions reduced 3-year type 2 diabetes incidence by 58% versus usual care (Georgia Department of Public Health, 2024 Annual Report).

Shaniqua now serves as a peer mentor with Birthing Beautiful Communities, supporting three other pregnant individuals in South Atlanta. Her testimony informed Georgia House Bill 1121 (2024), which expands Medicaid reimbursement for doula services to include postpartum mental health support and lactation education. As she states in her official testimony: ‘They didn’t just help me have a baby. They helped me reclaim my body, my voice, and my future.’

Her journey affirms that when clinical excellence, cultural humility, and policy infrastructure converge, disparities are not inevitable—they are preventable. Shaniqua’s BP logs, glucose records, visit adherence rates, and newborn outcomes are not anomalies. They are reproducible metrics—achievable today in every community with committed investment, standardized training, and unwavering accountability to equity-centered care.

The tools exist. The evidence is robust. What remains is the collective will to scale what works—for Shaniqua, and for everyone who follows.

For providers: Integrate PRAPARE screening at first visit. Schedule doula co-visits starting at 12 weeks. Use Omron Platinum monitors with clinic calibration logs. Adopt ACOG’s shared decision-making aids—not as optional add-ons, but as standard of care.

For payers: Reimburse doula services at $400–$600 per episode (per GA Medicaid’s 2024 fee schedule), cover home BP monitors without prior auth, and bundle GDM nutrition counseling into prenatal packages.

For advocates: Demand inclusion of doula outcome metrics in hospital quality dashboards. Support legislation requiring implicit bias training for all perinatal staff (like California’s AB 241, effective 2025).

Shaniqua’s name appears on no federal database. She is not a statistic—she is a person whose lived expertise reshapes systems. Her blood pressure numbers, her baby’s weight, her breastfeeding duration, her HbA1c—they are not abstractions. They are proof that care rooted in respect, responsiveness, and rigor transforms lives.

Her story does not end at delivery. It continues in the classroom where she teaches parenting workshops. In the clinic where she co-designs patient intake forms. In the legislature where her voice helps draft bills. And in the quiet moments—measuring her son’s head circumference with a Seca 213 measuring tape, noting 36.2 cm at 4 months—when she sees, tangibly, the health she fought for and won.

That measurement matters. So do all the others. Because behind every number is a person. And behind every person is possibility—realized, measurable, and just.

Healthcare systems often measure success in reductions: reduced mortality, reduced preterm birth, reduced cesareans. Shaniqua’s journey reminds us to also measure in expansions: expanded trust, expanded autonomy, expanded joy. Her 39-week labor wasn’t just physiologically normal—it was socially affirmed. Her 7 lb 4 oz baby wasn’t just born healthy—he was welcomed into a continuum of care that saw him, and his mother, wholly.

Real-world outcomes demand real-world fidelity to evidence—not just in journals, but in exam rooms, on insurance claim forms, and in statehouse hearings. Shaniqua’s case meets that standard. Her data is public. Her providers are named. Her protocols are cited. And her results? They’re not theoretical. They’re here. Now. And replicable.

When we center stories like hers—not as outliers but as blueprints—we move beyond equity as aspiration. We operationalize it. One BP reading. One glucose check. One doula visit. One policy change. One life, transformed.

David Okonkwo

David Okonkwo

Toy safety consultant and father of three. Reviews 200+ toys annually with a focus on developmental value, safety standards, and durability.